Takeda Pharmaceutical Company Limited Net Income per Employee (TAK), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Takeda Pharmaceutical Company Limited  (NYSE: TAK)
 

Takeda Pharmaceutical Limited Net Income per Employee

TAK's Quarterly Results, Trends, Rankings, Statistics
Takeda Pharmaceutical Limited's Income per employee fell in the fourth quarter 2025 on a trailing twelve month basis to $ 14,657, below the company average number of $35,771.
The Healthcare sector has seen employees of 55 other companies achieving higher income per employee. While Takeda Pharmaceutical Limited's total ranking has deteriorated compared to the previous quarter from 1718 to 1870.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TAK Net Income per Employee (Mar 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Mar 31 2024)
IV. Quarter
Y / Y Net Income Change -30.16 % - - - -55.09 %
Net Income per Employee (TTM) $ 14,657 20,987 20,987 20,987 20,987
TAK's Total Ranking # 1870 # 1718 # # #
Seq. Net Income Change - - - - -

TAK Company Profile >> Back to TAK Efficiency Comparisons >> Compare TAK Net Income per Employee to its Competitors

TAK Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 56
Healthcare Sector # 150
Overall Market # 1870

Net Income per Employee Statistics
High Average Low
$ 67,721 $ 35,771 $ 13,777
(Mar 31 2021)   (Mar 31 2025)







Companies with similar Income per Employee for 12 month ending Mar 31 2025, within Healthcare Sector Income per Employee Income 12 month ending Mar 31 2025Number of Employees Mar 31 2025
Integrated Biopharma Inc  25,080.00 $ 1.254  Million 50 
Tenet Healthcare Corp  23,757.58 $ 2,352.000  Million 99,000 
Nephros Inc   22,250.00 $ 0.801  Million 36 
Champions Oncology Inc   21,967.29 $ 4.701  Million 214 
Hca Healthcare Inc   20,875.00 $ 6,680.000  Million 320,000 
Becton Dickinson And Company  20,805.56 $ 1,498.000  Million 72,000 
Fonar Corporation  20,539.26 $ 10.680  Million 520 
Align Technology inc   20,185.51 $ 409.564  Million 20,290 
Chemed Corporation  19,526.85 $ 308.739  Million 15,811 
Gyre Therapeutics Inc   18,974.11 $ 11.726  Million 618 
Solventum Corporation  18,950.00 $ 379.000  Million 20,000 
Northview Acquisition Corp  17,933.35 $ 3.228  Million 180 
Protalix Biotherapeutics inc   17,292.04 $ 3.908  Million 226 
Quest Diagnostics Inc  16,631.58 $ 948.000  Million 57,000 
Henry Schein Inc   16,520.00 $ 413.000  Million 25,000 
Privia Health Group Inc   16,340.95 $ 20.034  Million 1,226 
Merit Medical Systems Inc  16,301.87 $ 122.264  Million 7,500 
Encompass Health Corporation  15,578.57 $ 654.300  Million 42,000 
Kewaunee Scientific Corporation  15,341.72 $ 11.583  Million 755 
Cadre Holdings inc   15,180.81 $ 38.453  Million 2,533 
Davita Inc   15,089.40 $ 1,176.973  Million 78,000 
Tactile Systems Technology Inc   14,912.52 $ 16.195  Million 1,086 
Takeda Pharmaceutical Company Limited  14,656.54 $ 688.857  Million 47,000 
Iqvia Holdings Inc   14,344.09 $ 1,334.000  Million 93,000 
Ufp Technologies Inc   13,097.81 $ 63.472  Million 4,846 
Nature s Sunshine Products inc   12,761.79 $ 10.286  Million 806 
Concentra Group Holdings Parent Inc   12,481.54 $ 162.260  Million 13,000 
Ardent Health Inc   12,413.57 $ 312.822  Million 25,200 
Phibro Animal Health Corporation  12,204.22 $ 31.792  Million 2,605 
Universal Health Services Inc   12,009.01 $ 1,218.915  Million 101,500 


Date modified: 2026-07-07T13:58:33+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.